Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Brain Neoplasms 34Glioblastoma 8Glioma 7Meningeal Carcinomatosis 6Epilepsy 5Neuroblastoma 4Neoplasms 4Neoplasm Metastasis 4Pituitary Neoplasms 3Meningioma 3Melanoma 3Lung Neoplasms 3Breast Neoplasms 3Seizures 2Retinoblastoma 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Paraganglioma 2Ovarian Neoplasms 2Oligodendroglioma 2Neuroma, Acoustic 2Neurofibromatosis 1 2Medulloblastoma 2Leukemia, Myeloid, Acute 2Delirium 2Central Nervous System Diseases 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Wilms Tumor 1Stroke 1

Interventions

Sevoflurane 1Propofol 1Nitrous Oxide 1Lidocaine 1Glycopyrrolate 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Abdominal Neoplasms × CNS × Clear all
NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡